PL2590949T3 - Sposób wytwarzania chinolino-3-karboksyamidów - Google Patents
Sposób wytwarzania chinolino-3-karboksyamidówInfo
- Publication number
- PL2590949T3 PL2590949T3 PL11732421T PL11732421T PL2590949T3 PL 2590949 T3 PL2590949 T3 PL 2590949T3 PL 11732421 T PL11732421 T PL 11732421T PL 11732421 T PL11732421 T PL 11732421T PL 2590949 T3 PL2590949 T3 PL 2590949T3
- Authority
- PL
- Poland
- Prior art keywords
- carboxamides
- quinoline
- manufacturing
- Prior art date
Links
- ACBLGRAOCIXXAL-UHFFFAOYSA-N Quinoline-3-carboxamides Chemical class C12=CC(C=3C=CN=CC=3)=CC=C2C(=O)C(C(=O)N)=CN1C1=CC=C(F)C=C1 ACBLGRAOCIXXAL-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36284910P | 2010-07-09 | 2010-07-09 | |
| EP10169162 | 2010-07-09 | ||
| EP11732421.0A EP2590949B1 (en) | 2010-07-09 | 2011-07-07 | Method for manufacturing of quinoline-3-carboxamides |
| PCT/EP2011/061490 WO2012004338A1 (en) | 2010-07-09 | 2011-07-07 | Method for manufacturing of quinoline-3-carboxamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2590949T3 true PL2590949T3 (pl) | 2016-06-30 |
Family
ID=43348982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11732421T PL2590949T3 (pl) | 2010-07-09 | 2011-07-07 | Sposób wytwarzania chinolino-3-karboksyamidów |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8871936B2 (pl) |
| EP (1) | EP2590949B1 (pl) |
| JP (1) | JP5881691B2 (pl) |
| KR (1) | KR101855195B1 (pl) |
| CN (1) | CN103119023B (pl) |
| AU (1) | AU2011275720B2 (pl) |
| BR (1) | BR112012033465A2 (pl) |
| CA (1) | CA2802006C (pl) |
| DK (1) | DK2590949T5 (pl) |
| EA (1) | EA021171B1 (pl) |
| ES (1) | ES2563208T3 (pl) |
| IL (1) | IL223583A (pl) |
| MX (1) | MX2013000288A (pl) |
| NZ (1) | NZ604176A (pl) |
| PL (1) | PL2590949T3 (pl) |
| PT (1) | PT2590949E (pl) |
| SG (1) | SG186430A1 (pl) |
| UA (1) | UA108381C2 (pl) |
| WO (1) | WO2012004338A1 (pl) |
| ZA (1) | ZA201209370B (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103626701A (zh) * | 2012-08-28 | 2014-03-12 | 天津药物研究院 | 一种制备喹啉衍生物的方法 |
| CN103626702A (zh) * | 2012-08-30 | 2014-03-12 | 天津药物研究院 | 一种制备喹啉酮衍生物的方法 |
| CN105367492B (zh) * | 2014-08-28 | 2018-07-03 | 杭州普晒医药科技有限公司 | 他喹莫德的晶型及其制备方法、其药物组合物和用途 |
| WO2016042112A1 (en) | 2014-09-23 | 2016-03-24 | Active Biotech Ab | Quinoline carboxamides for use in the treatment of multiple myeloma |
| ES2663836T3 (es) | 2014-11-19 | 2018-04-17 | Active Biotech Ab | Carboxamidas de quinolina para su uso en el tratamiento de leucemia |
| KR101807124B1 (ko) * | 2015-12-02 | 2017-12-07 | 현대자동차 주식회사 | 연료전지차량의 비상 운전 제어 방법 |
| CA3168070A1 (en) | 2020-03-03 | 2021-09-10 | Active Biotech Ab | Tasquinimod or a pharmaceutically acceptable salt thereof for use in combination therapy |
| CN111732540B (zh) * | 2020-07-20 | 2020-11-13 | 湖南速博生物技术有限公司 | 一种罗喹美克的制备方法 |
| AU2021313388A1 (en) | 2020-07-23 | 2023-01-19 | Erasmus University Medical Center Rotterdam (Erasmus Mc) | S100 proteins as novel therapeutic targets in myeloproliferative neoplasms |
| PL4277628T3 (pl) | 2021-01-18 | 2026-02-09 | Active Biotech Ab | Taskwinimod lub jego farmaceutycznie dopuszczalna sól do stosowania w leczeniu zespołu mielodysplastycznego |
| JP2024520307A (ja) | 2021-05-25 | 2024-05-24 | アクティブ バイオテック エイビー | 複数のタスキニモド粒子およびその使用 |
| JP2024524158A (ja) | 2021-07-02 | 2024-07-05 | アクティブ バイオテック エイビー | タスキニモドを含有する医薬製品および前記製品の純度を評価する方法 |
| KR102815351B1 (ko) | 2022-04-20 | 2025-05-29 | 국립목포대학교산학협력단 | 판막 석회화 예방 또는 치료용 조성물 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3769292A (en) * | 1972-04-28 | 1973-10-30 | Warner Lambert Co | N-(pyridyl)2h 1-benzothiopyran-3-carboxamide-4-hydroxy 1,1-dioxides |
| US3868379A (en) | 1972-04-28 | 1975-02-25 | Warner Lambert Co | Heterocyclic amides of 4-hydroxy-2H-1-benzothiopyran-3-carboxylic acid 1,1-dioxide |
| AT345847B (de) * | 1974-11-08 | 1978-10-10 | Thomae Gmbh Dr K | Verfahren zur herstellung neuer 4-hydroxy-2h- naphtho- (2,1-e)-1,2-thiazin-3-carboxamid-1,1-dioxid und deren salze |
| US4786644A (en) * | 1987-11-27 | 1988-11-22 | Hoechst-Roussel Pharmaceuticals Inc. | 1-aryl-3-quinolinecarboxamide |
| US5912349A (en) | 1997-01-31 | 1999-06-15 | Pharmacia & Upjohn Company | Process for the preparation of roquinimex |
| SE9801474D0 (sv) | 1998-04-27 | 1998-04-27 | Active Biotech Ab | Quinoline Derivatives |
| US6077851A (en) | 1998-04-27 | 2000-06-20 | Active Biotech Ab | Quinoline derivatives |
| US6133285A (en) | 1998-07-15 | 2000-10-17 | Active Biotech Ab | Quinoline derivatives |
| US7560557B2 (en) * | 2002-06-12 | 2009-07-14 | Active Biotech Ag | Process for the manufacture of quinoline derivatives |
| US6875869B2 (en) | 2002-06-12 | 2005-04-05 | Active Biotech Ab | Process for the manufacture of quinoline derivatives |
| SE0201778D0 (sv) * | 2002-06-12 | 2002-06-12 | Active Biotech Ab | Process for the manufacture of quinoline derivatives |
| EP2252299B1 (en) * | 2008-02-15 | 2014-03-19 | Merck Sharp & Dohme Corp. | Fused pyridone m1 receptor positive allosteric modulators |
| US8552194B2 (en) * | 2008-04-28 | 2013-10-08 | Actavis Group Ptc Ehf | Process for preparing quinoline-3-carboxamide derivatives |
-
2011
- 2011-07-07 EP EP11732421.0A patent/EP2590949B1/en active Active
- 2011-07-07 PL PL11732421T patent/PL2590949T3/pl unknown
- 2011-07-07 NZ NZ604176A patent/NZ604176A/en not_active IP Right Cessation
- 2011-07-07 UA UAA201300947A patent/UA108381C2/uk unknown
- 2011-07-07 PT PT117324210T patent/PT2590949E/pt unknown
- 2011-07-07 MX MX2013000288A patent/MX2013000288A/es active IP Right Grant
- 2011-07-07 CN CN201180033827.7A patent/CN103119023B/zh active Active
- 2011-07-07 AU AU2011275720A patent/AU2011275720B2/en not_active Ceased
- 2011-07-07 CA CA2802006A patent/CA2802006C/en active Active
- 2011-07-07 US US13/809,233 patent/US8871936B2/en active Active
- 2011-07-07 BR BR112012033465A patent/BR112012033465A2/pt not_active Application Discontinuation
- 2011-07-07 JP JP2013517387A patent/JP5881691B2/ja not_active Expired - Fee Related
- 2011-07-07 WO PCT/EP2011/061490 patent/WO2012004338A1/en not_active Ceased
- 2011-07-07 SG SG2012094371A patent/SG186430A1/en unknown
- 2011-07-07 KR KR1020137001660A patent/KR101855195B1/ko not_active Expired - Fee Related
- 2011-07-07 ES ES11732421.0T patent/ES2563208T3/es active Active
- 2011-07-07 DK DK11732421.0T patent/DK2590949T5/en active
- 2011-07-07 EA EA201300103A patent/EA021171B1/ru not_active IP Right Cessation
-
2012
- 2012-12-11 ZA ZA2012/09370A patent/ZA201209370B/en unknown
- 2012-12-12 IL IL223583A patent/IL223583A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| US8871936B2 (en) | 2014-10-28 |
| MX2013000288A (es) | 2013-05-22 |
| BR112012033465A2 (pt) | 2017-06-20 |
| CA2802006A1 (en) | 2012-01-12 |
| UA108381C2 (uk) | 2015-04-27 |
| WO2012004338A1 (en) | 2012-01-12 |
| EA201300103A1 (ru) | 2013-06-28 |
| IL223583A (en) | 2016-03-31 |
| JP2013529672A (ja) | 2013-07-22 |
| KR20130091730A (ko) | 2013-08-19 |
| CA2802006C (en) | 2018-09-25 |
| SG186430A1 (en) | 2013-01-30 |
| CN103119023B (zh) | 2014-12-24 |
| ZA201209370B (en) | 2014-03-26 |
| EA021171B1 (ru) | 2015-04-30 |
| US20130109860A1 (en) | 2013-05-02 |
| CN103119023A (zh) | 2013-05-22 |
| EP2590949A1 (en) | 2013-05-15 |
| EP2590949B1 (en) | 2015-11-25 |
| AU2011275720A1 (en) | 2013-01-10 |
| KR101855195B1 (ko) | 2018-05-08 |
| AU2011275720B2 (en) | 2015-05-14 |
| DK2590949T5 (en) | 2016-05-23 |
| JP5881691B2 (ja) | 2016-03-09 |
| NZ604176A (en) | 2014-10-31 |
| HK1183864A1 (zh) | 2014-01-10 |
| PT2590949E (pt) | 2016-03-07 |
| ES2563208T3 (es) | 2016-03-11 |
| DK2590949T3 (en) | 2016-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL248217B (en) | A method for the production of inganol-3-englate | |
| ZA201209370B (en) | Method for manufacturing of quinoline-3-carboxamides | |
| IL207945A0 (en) | Method for the production of carbohydrates | |
| GB201016436D0 (en) | Method of making solid beads | |
| ZA201305972B (en) | Method for the preparation of biphephos | |
| PT2627629T (pt) | Método para a preparação de isocianatos | |
| GB2485831B (en) | A method of manufacturing a component | |
| EP2610338A4 (en) | PROCESS FOR PRODUCTION OF SUBSTANCE | |
| GB201008900D0 (en) | Method of machining | |
| EP2653482A4 (en) | PROCESS FOR PRODUCING PSEUDOPOLYROTAXANE | |
| AP3415A (en) | Method for manufacturing of naltrexone | |
| EP2557903A4 (en) | METHOD FOR PRODUCING AN EXTERNAL LEADER | |
| GB201007454D0 (en) | Method of determining tolerance | |
| PL2476684T3 (pl) | Sposób wytwarzania alkilofosforanów | |
| GB201006348D0 (en) | Method of manufacturing a component | |
| PL2476685T3 (pl) | Sposób wytwarzania alkilofosforanów | |
| GB201114798D0 (en) | Method of modifying surfaces | |
| EP2586774A4 (en) | PROCESS FOR THE PREPARATION OF RANOLAZINE | |
| GB201007207D0 (en) | Method | |
| GB201119607D0 (en) | Method of manufacture | |
| PL2476686T3 (pl) | Sposób wytwarzania alkilofosforanów | |
| GB201102475D0 (en) | Method of reducing offset | |
| GB201007522D0 (en) | Method | |
| PL389965A1 (pl) | Sposób wytwarzania 3ß - hydroksy-17 a-oxa-D-homo-5α-androst-17-onu | |
| EP2496096A4 (en) | PROCESS FOR PRODUCING MAGNOLIIDAE COMPOUNDS |